Health CS Mutahi Kagwe has assured people living with HIV of the government's plan to make available antiretroviral medication.
This comes amid reports that there is a shortage and a stock-out for regular tests for adults and kids.
In a meeting with representatives of people living with HIV, Kagwe said the Ministry of Health will continue stakeholder engagement to address challenges in HIV response.
"We reassure the public that there are enough antiretroviral medications for all clients despite the reduced dispensation period to every client," he said on Wednesday.
"The Ministry of Health is also making every effort to ensure there is stable supply of all HIV commodities in the country by end of January 2022."
Kenya recently experienced a temporary disruption in the supply of ARVs, which affected its distribution of early infant diagnosis reagents for people living with HIV.
The country is also facing a disruption in the supply of laboratory reagents
"As a result, eligible people living with HIV have been receiving less than the three-months’ supply of medications that they were initially receiving," Kagwe said.
On Tuesday, People living with HIV wrote to President Uhuru Kenyatta asking him to intervene, saying petitions to the Ministry of Health and the National Aids and STI Control Programme had been ignored.
"Children are being turned away without tests, resulting in inexcusable and dangerous delays in initiating HIV-positive children onto life-saving treatment," the petitioners said in the letter to the President.
They also accused the Ministry of Health of introducing a requirement that all children with HIV receive viral load testing before they are put on Dolutegravir, the most powerful ARV on the market today.
During the meeting with the Health CS, they resolved that the government expedites procurement processes of the antiretroviral medication to have them in the country in the next 3 to 4 weeks.
They asked the government to also explore local manufacturing of ARVs for sustainable supply in future.
